Clinical Study of Injectable Ceramics Bone Graft Substitute Containing rhBMP-2
NCT ID: NCT02714829
Last Updated: 2018-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2016-04-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral
NCT05717478
Sinus Floor Elevation Using Alpha-Bio's GRAFT Natural Bovine Bone vs. Commercially Available Bone Graft
NCT02384291
Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
NCT03215667
Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials
NCT03149172
In Vivo Clinical Trial of Porous Starch - Hydroxyapatite Composite Biomaterials for Bone Regeneration
NCT02910232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inject BMP
ExcelOS-inject containing rhBMP-2
Inject BMP
Injection of ExcelOS-inject(beta-TCP) containing rhBMP-2.
ExcelOS-inject
ExcelOS-inject without rhBMP-2
ExcelOS-inject
Injection of ExcelOS-inject(beta-TCP) without rhBMP-2.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inject BMP
Injection of ExcelOS-inject(beta-TCP) containing rhBMP-2.
ExcelOS-inject
Injection of ExcelOS-inject(beta-TCP) without rhBMP-2.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioAlpha Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soon Jung Hwang, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Dental Hospital
Jong-Rak Hong, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center
Hee-Kyun Oh, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Chonnam National University
References
Explore related publications, articles, or registry entries linked to this study.
Han JJ, Chang AR, Ahn J, Jung S, Hong J, Oh HK, Hwang SJ. Efficacy and safety of rhBMP/beta-TCP in alveolar ridge preservation: a multicenter, randomized, open-label, comparative, investigator-blinded clinical trial. Maxillofac Plast Reconstr Surg. 2021 Dec 20;43(1):42. doi: 10.1186/s40902-021-00328-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ExcelOS 14-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.